Related Experiment Video
Updated: Jun 22, 2026

An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis
Published on: February 8, 2019
The diagnosis of vasculitis
1Addenbrooke's Hospital, Renal Unit, Cambridge, UK. dj106@cam.ac.uk
Early diagnosis of primary systemic vasculitis is crucial for timely treatment and improved outcomes. Anti-neutrophilic cytoplasmic antibody testing aids in identifying a key subgroup, facilitating earlier detection of small-vessel vasculitides.
Area of Science:
- Rheumatology
- Immunology
- Internal Medicine
Background:
- Primary systemic vasculitis diagnosis is challenging due to its heterogeneous nature.
- Early diagnosis is critical to initiate therapy and prevent organ damage and poor prognosis.
- Anti-neutrophilic cytoplasmic antibody (ANCA) testing has improved the diagnosis of small-vessel vasculitides.
Purpose of the Study:
- To highlight the importance of early diagnosis in primary systemic vasculitis.
- To discuss the diagnostic challenges and available tools for vasculitis.
- To emphasize the role of ANCA testing in specific vasculitis subgroups.
Main Methods:
- Review of diagnostic approaches for primary systemic vasculitis.
- Discussion of the utility of ANCA testing in small-vessel vasculitides.
- Exploration of diagnostic criteria, exclusion of mimics, and role of clinical presentation, laboratory tests, imaging, and histology.
Main Results:
- Heterogeneity of vasculitis poses significant diagnostic challenges.
- ANCA testing is beneficial for identifying and diagnosing a subgroup of small-vessel vasculitides.
- Diagnosis often relies on clinical suspicion, supported by investigations and histology, with observation and therapeutic trials for uncertain cases.
Conclusions:
- Early suspicion and comprehensive investigation are key to diagnosing primary systemic vasculitis.
- ANCA testing is a valuable tool for specific vasculitis subtypes.
- When diagnosis is uncertain, a stepwise approach including observation and therapeutic trials may be necessary.
Related Concept Videos
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Myocarditis II: Clinical Features and Diagnostic Tests
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Pericarditis II: Clinical Features and Diagnostic Tests
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
